Rockwell Medical's iron deficiency drug succeeds in trial

(Reuters) - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving hemoglobin levels in patients with chronic kidney disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news